BMRN - Biomarin Pharmaceutical Inc - SEC Form 4 Insider Trading Screener

Manufactured Goods - Chemicals - Pharmaceutical Preparations - BMRN (1048477)
General
Tickers
Insider
Sh Price $
Lqdty M$
Date
Filing Date
  
Trade Date
  
Filing Delay
N Days Ago
Transaction Filing
 P - Purchase
 S - Sale
 A - Grant
 D - Sale to Iss
 G - Gift
 F - Tax
 M - Option Ex
 X - Option Ex
 C - Cnv Deriv
 W - Inherited
No deriv Multiple Days
Traded K$
Own Chg %
Industry
Insider Title     Officer
    COB
    CEO
    Pres
    COO
    CFO
    GC
    VP
  Director
  10%own
  Other
Group by
Sort by
Max Results
Page
   clear
38 results. Finviz - SEC - Yahoo - Stockcharts - Tradingview
TCcnt1d1w1m6m

X

Filing Date

Trade Date

Ticker

Insider Name

Title

Trade Type  

Price

Qty

Owned

ΔOwn

Value

1d

1w

1m

6m

2024-11-12
BMRNGuyer Charles GregEVP, Chief Technical OfficerS - Sale$66.37-5,27868,909-7%-$350,324
2024-08-13
BMRNBurkhart ErinGVP, Chief Accounting OfficerS - Sale$90.00-71414,449-5%-$64,260
D
2024-05-30
BMRNMueller BrianEVP, CFOS - Sale+OE$75.19-5,00072,159-6%-$375,950
D
2024-05-28
BMRNDavis George EricEVP, GCS - Sale+OE$74.51-40,85056,157-42%-$3,043,802
DM
2024-05-09
BMRNBienaime Jean JacquesDirS - Sale+OE$81.38-40,000722,527-5%-$3,255,200
D
2024-05-02
BMRNDavis George EricEVP, GCS - Sale+OE$85.01-1,85056,157-3%-$157,269
2024-05-02
BMRNAjer Jeffrey RobertEVP, Chief Commercial OfficerS - Sale$82.91-5,00066,767-7%-$414,550
DM
2024-04-11
BMRNBienaime Jean JacquesDirS - Sale+OE$91.13-40,000722,527-5%-$3,645,000
2024-04-10
BMRNBurkhart ErinGVP, Chief Accounting OfficerS - Sale$90.00-2,28616,156-12%-$205,740
2024-03-28
BMRNDavis George EricEVP, GCS - Sale$88.34-24,60255,856-31%-$2,173,341
2024-03-05
BMRNFuchs Henry JPres, Worldwide R, DS - Sale$85.18-35,341212,117-14%-$3,010,396
M
2024-03-05
BMRNBienaime Jean JacquesDirS - Sale$86.11-2,000807,7360%-$172,223
2024-03-05
BMRNAjer Jeffrey RobertEVP, Chief Commercial OfficerS - Sale$87.07-4,00094,047-4%-$348,280
2024-02-27
BMRNBienaime Jean JacquesDirS - Sale$90.35-1,000809,7360%-$90,350
DM
2024-02-08
BMRNBienaime Jean JacquesDirS - Sale+OE$89.03-30,000667,135-4%-$2,670,750
DM
2024-01-09
BMRNBienaime Jean JacquesDirS - Sale+OE$97.29-20,000672,695-3%-$1,945,700
D
2023-12-21
BMRNBienaime Jean JacquesDirS - Sale+OE$93.99-10,000672,645-1%-$939,900
2023-12-13
BMRNDavis George EricEVP, GCS - Sale$95.30-13,76455,710-20%-$1,311,709
2023-08-16
BMRNAjer Jeffrey RobertEVP, Chief Commercial OfficerS - Sale$90.00-5,00060,804-8%-$450,000
2023-08-10
BMRNFuchs Henry JPres, Worldwide R, DS - Sale$90.43-12,000176,187-6%-$1,085,111
2023-08-09
BMRNGuyer Charles GregEVP, Chief Technical OfficerS - Sale$93.30-5,36040,041-12%-$500,109
2023-08-08
BMRNDavis George EricEVP, GCS - Sale$89.42-11,00069,474-14%-$983,662
M
2023-08-07
BMRNBienaime Jean JacquesCEOS - Sale$88.21-10,000670,265-1%-$882,140
D
2023-05-11
BMRNBienaime Jean JacquesCEOS - Sale+OE$94.67-30,000673,746-4%-$2,840,226
DM
2023-05-09
BMRNBienaime Jean JacquesCEOS - Sale+OE$94.89-60,000673,746-8%-$5,693,371
D
2023-04-10
BMRNBienaime Jean JacquesCEOS - Sale+OE$99.56-10,000673,429-1%-$995,600
D
2023-04-06
BMRNBienaime Jean JacquesCEOS - Sale+OE$96.13-10,000673,429-1%-$961,300
D
2023-04-03
BMRNLawlis V BryanDirS - Sale+OE$97.09-8,50028,950-23%-$825,265
DM
2023-03-10
BMRNBienaime Jean JacquesCEOS - Sale+OE$91.64-23,000735,389-3%-$2,107,800
DM
2023-02-10
BMRNBienaime Jean JacquesCEOS - Sale+OE$109.84-21,000567,757-4%-$2,306,550
D
2023-01-25
BMRNAjer Jeffrey RobertEVP, Chief Commercial OfficerS - Sale+OE$115.70-49,00041,088-54%-$5,669,134
DM
2023-01-13
BMRNBienaime Jean JacquesCEOS - Sale+OE$111.90-20,000567,957-3%-$2,238,000
D
2023-01-13
BMRNMueller BrianEVP, CFOS - Sale+OE$114.50-2,50027,746-8%-$286,250
D
2022-12-13
BMRNMueller BrianEVP, CFOS - Sale+OE$107.50-2,50027,746-8%-$268,750
2022-12-13
BMRNBienaime Jean JacquesCEOS - Sale$106.89-1,000567,9570%-$106,890
D
2022-12-02
BMRNMueller BrianEVP, CFOS - Sale+OE$104.50-7,00127,746-20%-$731,605
2022-12-02
BMRNBienaime Jean JacquesCEOS - Sale$103.98-1,500568,9570%-$155,967
D
2022-11-23
BMRNMueller BrianEVP, CFOS - Sale+OE$98.73-5,37928,847-16%-$531,092

AAmended filing
DDerivative transaction in filing (usually option exercise)
EError detected in filing
MMultiple transactions in filing; earliest reported transaction date and weighted average transaction price
S - SaleSale of securities on an exchange or to another person
S - Sale+OESale of securities on an exchange or to another person (after option exercise)
F - TaxPayment of exercise price or tax liability using portion of securities received from the company
P - PurchasePurchase of securities on an exchange or from another person
Return to top